News
We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...
StockStory.org on MSN2d
BIIB Q1 Earnings Call: New Product Growth Outpaces Declining MS Franchise Amid Lowered GuidanceBiotech company Biogen (NASDAQ:BIIB) in Q1 CY2025, with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
A large chunk of the fund’s assets (often 20% or more) sits in biotech and pharma stocks, including its biggest four holdings, Eli Lilly LLY, AstraZeneca AZN, Biogen BIIB, and Amgen AMGN.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Just because a business does not make any money, does not mean that the stock will go down. For example, although... WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc ...
Visit a quote page and your recently viewed tickers will be displayed here.
Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results